Algernon Pharmaceuticals Inc (AGNPF)

[medchem]

To be clear:

South korea "results" will not be arriving soon. They have to start the trial first man. The next step is getting the South Korean government and health authorities to accept their trial application. It is, and has been, under review.

When the trial commences, this is going to get even more media attention. It will probably take a couple of weeks of the trial up and running to know whether Ifenprodil saves the lungs and neurons as we hope it will.

And also don't forget, this isn't a one trick pony.

I personally am more interested in what this can do for chronic cough then for covid. Why? Because I have reviewed the scientific studies done by Mark Williams showing that Ifenprodil beats Big Pharma's best medication for chronic cough and IPF. You know what that means? Billions of dollars.